IBBQ Among Technology ETFs
End-of-day Nov 18, 2026 · 54 Technology ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.6% | −6.0% | −2.0% | −3.0% | +22.5% | +25.7% | +91.4% | +48.6% | — | +42.0% |
| Peer average | +0.3% | −6.2% | −9.7% | −12.1% | +2.0% | +5.0% | +65.2% | +23.5% | +365.5% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$92 of every $1,000 in IBBQ is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.24% | $923.62 | 70K | $11.7M |
| 2 | AMGNAmgen | Healthcare | 8.68% | $867.72 | 24K | $11.0M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.97% | $796.69 | 19K | $10.1M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.35% | $635.19 | 8,481 | $8.1M |
| 5 | MRNAModerna | Healthcare | 5.67% | $567.01 | 33K | $7.2M |
| 6 | BIIBBiogen | Healthcare | 2.45% | $245.29 | 12K | $3.1M |
| 7 | RVMDRevolution Medicines | Healthcare | 2.36% | $235.94 | 18K | $3.0M |
| 8 | RPRXRoyalty Pharma | Healthcare | 2.01% | $201.39 | 37K | $2.6M |
| 9 | ILMNIllumina | Healthcare | 1.97% | $197.43 | 13K | $2.5M |
| 10 | ROIVRoivant Sciences | Healthcare | 1.84% | $183.87 | 61K | $2.3M |
| 11 | INSMInsmed | Healthcare | 1.77% | $176.86 | 18K | $2.2M |
| 12 | ARGNFArgenx SE | — | 1.71% | $170.65 | 2,282 | $2.2M |
| 13 | UTHRUnited Therapeutics | Healthcare | 1.67% | $166.61 | 3,604 | $2.1M |
| 14 | INCYIncyte | Healthcare | 1.61% | $160.99 | 17K | $2.0M |
| 15 | VTRSViatris | Healthcare | 1.57% | $157.14 | 96K | $2.0M |
of the $347B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.24% |
| 2 | AMGN | Amgen | 8.68% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.97% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.35% |
| 5 | MRNA | Moderna | 5.67% |
| 6 | BIIB | Biogen | 2.45% |
| 7 | RVMD | Revolution Medicines | 2.36% |
| 8 | RPRX | Royalty Pharma | 2.01% |
| 9 | ILMN | Illumina | 1.97% |
| 10 | ROIV | Roivant Sciences | 1.84% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.23 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0342 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0361 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0906 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0958 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0287 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0402 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0619 |
| Sep 23, 2024 | Sep 27, 2024 | $0.0894 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0506 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0435 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0526 |